Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Souvenaid

- PMLiVE

Novartis’ lung cancer drug wins FDA Breakthrough Therapy Designation

Provides hope for new treatment of rare cancer

Roche Basel Switzerland

Roche scores EU approval twice for Tecentriq in lung cancer

Carves out space in a market dominated by MSD's Keytruda

- PMLiVE

Genentech agrees trade secret theft settlement with Taiwan’s JHL

Three ex-Genetech workers pleaded not guilty to criminal theft charges

- PMLiVE

All Change: The Challenges of Embracing a Plant-Based Diet

Rick Wilson – Director of Nutrition and Dietetics at Kings College Hospital for 30 years up to his retirement in 2015, BSc. RD (retired) – looks at some of the...

Say Communications

- PMLiVE

Third strike for BMS’ Opdivo in brain cancer

Despite failing first endpoint, trial is set to continue

- PMLiVE

Bedrock creates waves

The Bedrock team were awash with ideas at their summer watersports and BBQ event. All were Bravely Bedrock in a host of activities – including wakeboarding, paddle boarding and taming...

Bedrock Healthcare Communications

Celebrating Ten Magical Years with Clare Reynolds

Lucid loves to recognise and celebrate the magic people create for their clients, teams and patients. This month it was time to recognise the outstanding contribution that Clare Reynolds has...

Lucid Group Communications Limited

- PMLiVE

MSD’s Keytruda catches up in kidney cancer

Combination therapy approved in EU for all risk groups

- PMLiVE

Origin opens new facility in Alderley Park

Plans to support UK pharma start-ups

- PMLiVE

Pharma ranks bottom in Gallup poll of industry reputation

US opioid epidemic and medicine pricing to blame

- PMLiVE

Boehringer bolsters KRAS push with $720m Lupin deal

Signs of progress in the field are emerging

- PMLiVE

New hires at Bayer, Eisai and Accord Healthcare

The latest movers in pharma

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links